Treatment Response in Dialysis Anaemia

PHASE4CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

April 30, 2017

Conditions
AnaemiaHaemodialysis
Interventions
DRUG

Iron sucrose

1gram of iron sucrose (5 200mg aliquots) administered if participant's haemoglobin is less than 9.5g/dl

DRUG

Erythopoietin stimulating agent

Incremental increase in dose of erythropoeitin stimulating agent being administered as per a pre-defined criteria

Trial Locations (2)

W12 0HS

Imperial Renal and Transplant Centre, London

Unknown

Imperial NHS Healthcare Trust, London

All Listed Sponsors
lead

Imperial College Healthcare NHS Trust

OTHER

NCT02707757 - Treatment Response in Dialysis Anaemia | Biotech Hunter | Biotech Hunter